180 Life Sciences Corp (ATNF)
3.43
-0.31
(-8.29%)
USD |
NASDAQ |
Nov 04, 16:00
3.45
+0.02
(+0.58%)
After-Hours: 20:00
180 Life Sciences Enterprise Value: 2.922M for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 2.922M |
| October 31, 2024 | 3.097M |
| October 30, 2024 | 3.106M |
| October 29, 2024 | 3.591M |
| October 28, 2024 | 3.397M |
| October 25, 2024 | 3.426M |
| October 24, 2024 | 3.058M |
| October 23, 2024 | 3.417M |
| October 22, 2024 | 3.843M |
| October 21, 2024 | 4.115M |
| October 18, 2024 | 4.173M |
| October 17, 2024 | 3.494M |
| October 16, 2024 | 5.569M |
| October 15, 2024 | 0.7698M |
| October 14, 2024 | 0.6147M |
| October 11, 2024 | 0.5759M |
| October 10, 2024 | 0.5662M |
| October 09, 2024 | 0.6243M |
| October 08, 2024 | 0.4401M |
| October 07, 2024 | 0.6534M |
| October 04, 2024 | 0.6728M |
| October 03, 2024 | 0.634M |
| October 02, 2024 | 0.6631M |
| October 01, 2024 | 0.7892M |
| September 30, 2024 | 0.9152M |
| Date | Value |
|---|---|
| September 27, 2024 | 0.9249M |
| September 26, 2024 | 0.9928M |
| September 25, 2024 | 1.109M |
| September 24, 2024 | 1.109M |
| September 23, 2024 | 1.100M |
| September 20, 2024 | 1.206M |
| September 19, 2024 | 1.158M |
| September 18, 2024 | 1.264M |
| September 17, 2024 | 1.226M |
| September 16, 2024 | 1.070M |
| September 13, 2024 | 1.051M |
| September 12, 2024 | 1.235M |
| September 11, 2024 | 1.002M |
| September 10, 2024 | 1.061M |
| September 09, 2024 | 1.119M |
| September 06, 2024 | 1.187M |
| September 05, 2024 | 1.187M |
| September 04, 2024 | 1.72M |
| September 03, 2024 | 1.012M |
| August 30, 2024 | 1.051M |
| August 29, 2024 | 1.070M |
| August 28, 2024 | 1.177M |
| August 27, 2024 | 1.148M |
| August 26, 2024 | 1.196M |
| August 23, 2024 | 1.284M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-0.9052M
Minimum
Dec 12 2023
361.77M
Maximum
Apr 12 2021
64.82M
Average
29.22M
Median
Enterprise Value Benchmarks
| Seelos Therapeutics Inc | 10.27M |
| NovaBay Pharmaceuticals Inc | 3.615M |
| Palatin Technologies Inc | 13.93M |
| iBio Inc | 9.837M |
| Theriva Biologics Inc | -12.69M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.0118M |
| Total Expenses (Quarterly) | 1.847M |
| EPS Diluted (Quarterly) | 0.01 |
| Earnings Yield | -825.4% |